搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
Tourmaline Bio第四季度亏损扩大 股价下跌
纽约 - 临床阶段生物科技公司Tourmaline Bio, Inc. (NASDAQ: TRML )周三报告称,由于研发支出增加,第四季度亏损扩大。财报发布后,公司股价下跌2%。 2024年第四季度,公司净亏损为2,220万美元,每股亏损0.86美元,而去年同期亏损1,290万美元,每股亏损0.81美元。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Signs order to dismantle
US offers $15M reward
3 found dead inside home
China executes 4 Canadians?
Las Vegas columnist dies
LA Crips leader charged
Green beans recalled
Detainees flee from custody
Family is suing Boeing
Announces hiring freeze
J.Crew signs exclusive deal
DOGE data access blocked
Non-citizens can't vote
New drug could reduce risk?
Mount Spurr eruption likely
Venus to make a rare pass
Taliban frees American man
Tesla arson suspects charged
Dark energy findings
Oxygen in most distant galaxy
Cleared in funds probe
Michigan hospital shooting
Updates US travel advice
Bruce Willis turns 70
Tesla Cybertruck recall
NHL's front office iPad app
Pentagon restores webpages
Malaysia OKs new search
Elected new IOC president
Sold to William Chisholm?
Weekly jobless claims rise
Iran releases French citizen
US home sales rose
Coach DeChellis retires
Turkey detains dozens
反馈